Mr. Chirayu Amin (DIN: 00242549) appointed as Executive Chairman of Alembic Pharmaceuticals effective 1st April, 2026 for 5 years.
Appointment was approved by shareholders at the 15th AGM held on 5th August, 2025; not liable to retire by rotation.
Mr. Amin simultaneously relinquished the CEO position upon completion of his former tenure as Chairman & CEO on 31st March, 2026.
Disclosure filed under Regulation 30 of SEBI LODR 2015, referencing SEBI Master Circular dated 30th January 2026.